ATE410407T1 - Zimtsäureamidderivate - Google Patents

Zimtsäureamidderivate

Info

Publication number
ATE410407T1
ATE410407T1 AT03740425T AT03740425T ATE410407T1 AT E410407 T1 ATE410407 T1 AT E410407T1 AT 03740425 T AT03740425 T AT 03740425T AT 03740425 T AT03740425 T AT 03740425T AT E410407 T1 ATE410407 T1 AT E410407T1
Authority
AT
Austria
Prior art keywords
acid amide
cinnamic acid
amide derivatives
derivatives
cinnamic
Prior art date
Application number
AT03740425T
Other languages
English (en)
Inventor
Synese Jolidon
Sarmiento Rosa Rodriguez
Andrew Thomas
Wolfgang Wostl
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE410407T1 publication Critical patent/ATE410407T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03740425T 2002-07-15 2003-07-07 Zimtsäureamidderivate ATE410407T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02015583 2002-07-15

Publications (1)

Publication Number Publication Date
ATE410407T1 true ATE410407T1 (de) 2008-10-15

Family

ID=30011071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740425T ATE410407T1 (de) 2002-07-15 2003-07-07 Zimtsäureamidderivate

Country Status (20)

Country Link
US (1) US6900354B2 (de)
EP (1) EP1523469B1 (de)
JP (1) JP4108679B2 (de)
KR (1) KR20050029206A (de)
CN (1) CN1305838C (de)
AR (1) AR040489A1 (de)
AT (1) ATE410407T1 (de)
AU (1) AU2003281030B2 (de)
BR (1) BR0312658A (de)
CA (1) CA2493372A1 (de)
DE (1) DE60323981D1 (de)
ES (1) ES2314219T3 (de)
MX (1) MXPA05000583A (de)
PA (1) PA8577201A1 (de)
PE (1) PE20040667A1 (de)
PL (1) PL373390A1 (de)
RU (1) RU2318802C2 (de)
TW (1) TW200404760A (de)
UY (1) UY27894A1 (de)
WO (1) WO2004007429A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588704A1 (de) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamidderivate zur Behandlung des Restless-Leg-Syndroms und der Suchterkrankungen
CA2566094A1 (en) 2004-05-26 2005-12-08 Eisai R & D Management Co., Ltd. Cinnamide compound
AU2005297966B2 (en) * 2004-10-26 2010-12-23 Eisai R & D Management Co., Ltd. Amorphous object of cinnamide compound
CN101128189A (zh) 2005-02-25 2008-02-20 弗·哈夫曼-拉罗切有限公司 药物物质分散性改善的片剂
EP1868595B1 (de) * 2005-04-01 2012-01-11 Wellstat Therapeutics Corporation Verbindungen zur behandlung von stoffwechselstörungen
US8138209B2 (en) * 2005-07-13 2012-03-20 Jenrin Discovery, Inc. Substituted picolinamides as MAO-B inhibitors useful for treating obesity
PL209602B1 (pl) 2005-10-20 2011-09-30 Inst Chemii Bioorg Pan Sposób otrzymywania amidu kwasu 3-(4-hydroksyfenylo)propanowego
CN101309916A (zh) * 2005-11-18 2008-11-19 卫材R&D管理有限公司 制备肉桂酰胺衍生物的方法
EP1953151A4 (de) * 2005-11-18 2010-06-02 Eisai R&D Man Co Ltd Salze aus einer cynnamidverbindung oder solvate daraus
ZA200803939B (en) * 2005-11-24 2009-10-28 Eisai R&D Man Co Ltd Morpholine type cinnamide compound
TWI370130B (en) * 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
BRPI0618814A2 (pt) * 2005-11-24 2014-04-29 Eisai R&D Man Co Ltd Composto ou um sal farmacologicamente aceitável do mesmo, e, agente farmacêutico
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US7737141B2 (en) * 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
CL2008000582A1 (es) * 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
WO2008140111A1 (ja) * 2007-05-16 2008-11-20 Eisai R & D Management Co., Ltd. シンナミド誘導体のワンポット製造方法
US7986144B2 (en) * 2007-07-26 2011-07-26 Schlumberger Technology Corporation Sensor and insulation layer structure for well logging instruments
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
CA2694401C (en) 2007-08-31 2012-12-04 Eisai R&D Management Co., Ltd. Polycyclic compound
WO2009096349A1 (ja) * 2008-01-28 2009-08-06 Eisai R & D Management Co., Ltd. 結晶性のシンナミド化合物またはその塩
NL2005655A (en) 2009-12-09 2011-06-14 Asml Netherlands Bv A lithographic apparatus and a device manufacturing method.
CN104030941B (zh) * 2014-06-23 2016-04-27 常州大学 一种3-（4-羟基苯基）丙酰胺的合成方法
CN107011313B (zh) 2016-01-27 2021-11-30 天士力医药集团股份有限公司 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用
KR20200108015A (ko) 2018-01-10 2020-09-16 브라이트씨드, 인크. 대사를 조절하기 위한 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645019A1 (de) 1989-03-30 1990-10-05 Fournier Innovation Synergie
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
WO1997033572A1 (en) 1996-03-15 1997-09-18 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neurophathy by administering selegiline
WO2001034172A2 (en) 1999-11-05 2001-05-17 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
CN1665774A (zh) 2005-09-07
DE60323981D1 (de) 2008-11-20
MXPA05000583A (es) 2005-04-19
AR040489A1 (es) 2005-04-06
UY27894A1 (es) 2003-12-31
TW200404760A (en) 2004-04-01
PE20040667A1 (es) 2004-09-25
AU2003281030A1 (en) 2004-02-02
EP1523469B1 (de) 2008-10-08
CA2493372A1 (en) 2004-01-22
KR20050029206A (ko) 2005-03-24
AU2003281030B2 (en) 2009-05-28
PA8577201A1 (es) 2004-02-07
WO2004007429A1 (en) 2004-01-22
US6900354B2 (en) 2005-05-31
RU2005104104A (ru) 2005-10-10
RU2318802C2 (ru) 2008-03-10
PL373390A1 (en) 2005-08-22
JP4108679B2 (ja) 2008-06-25
US20040034096A1 (en) 2004-02-19
CN1305838C (zh) 2007-03-21
JP2005533092A (ja) 2005-11-04
ES2314219T3 (es) 2009-03-16
EP1523469A1 (de) 2005-04-20
BR0312658A (pt) 2005-04-26

Similar Documents

Publication Publication Date Title
ATE410407T1 (de) Zimtsäureamidderivate
ATE499347T1 (de) Amidderivate
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
ATE368042T1 (de) Cephemverbindungen
DE60312848D1 (de) Verbindungsanschluss
NO20044046L (no) Substituerte hydroksyetylaminer
IS7381A (is) Efnasambönd
DE60305578D1 (de) T-mutter
IS7414A (is) Oxó-azabísýklísk efnasambönd
DK1652843T3 (da) Amidderivater
NO20045659L (no) Forbindelser
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
ATE423771T1 (de) Tetrahydrochinolinderivate
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
ATE457299T1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
DE50306664D1 (de) Zimtsäureamide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1523469

Country of ref document: EP

REN Ceased due to non-payment of the annual fee